Two Roche Alzheimer’s Assays Win US FDA Breakthrough Device Status
Executive Summary
The company is getting its data ready for submission to FDA for the Elecsys cerebrospinal fluid assays and hopes the new Breakthrough Device designation will increase interaction with the agency and speed the path to approval.